Literature DB >> 10391263

Aortic root replacement with the freestyle stentless porcine aortic root bioprosthesis.

N D Kon1, A R Cordell, S M Adair, J E Dobbins, D W Kitzman.   

Abstract

BACKGROUND: Stentless porcine prosthetic valves offer several advantages over traditional valves. Among these are superior hemodynamics, laminar flow patterns, lack of need for anticoagulation and perhaps improved durability.
METHODS: One hundred and twelve patients were operated on from September 17, 1992 to April 13, 1998 as part of a multi-center worldwide investigation. All patients received a total aortic root replacement. Patients were evaluated postoperatively at discharge, 3 to 6 months, and yearly by clinical exam and color flow Doppler echocardiography.
RESULTS: There were 4 deaths either in the hospital or within 30 days after surgery for an operative mortality of 3.6%. No patients experienced structural valve deterioration, non-structural valve deterioration, paravalvular leak, unacceptable hemodynamic performance, or postoperative endocarditis. The linearized rates for survival and thromboembolic complications at 5 years were 82.8% and 90.5% respectively. Excellent hemodynamic function is demonstrated by very low gradients, large EOA, and an exceedingly low incidence of any aortic regurgitation.
CONCLUSIONS: The Medtronic Freestyle aortic root bioprosthesis can be used safely to replace the aortic root for aortic valve and aortic root pathology. Root replacement allows optimal hemodynamic performance with no significant aortic regurgitation. Early and intermediate results are encouraging, but further follow-up is needed to determine valve durability.

Entities:  

Mesh:

Year:  1999        PMID: 10391263     DOI: 10.1016/s0003-4975(99)00370-7

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

1.  Resolution of perivalvular hematoma of the Freestyle stentless aortic root bioprosthesis implanted with a subcoronary technique.

Authors:  Y Takami; H Ina
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-11

Review 2.  Surgical Treatment of Valvular Heart Disease: Overview of Mechanical and Tissue Prostheses, Advantages, Disadvantages, and Implications for Clinical Use.

Authors:  Amy G Fiedler; George Tolis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-02-05

Review 3.  Porcine models of muscular dystrophy.

Authors:  Joshua T Selsby; Jason W Ross; Dan Nonneman; Katrin Hollinger
Journal:  ILAR J       Date:  2015

Review 4.  Biological aortic valve replacement: advantages and optimal indications of stentless compared to stented valve substitutes. A review.

Authors:  Reza Tavakoli; Pichoy Danial; Ahmed Hamid Oudjana; Peiman Jamshidi; Max Gassmann; Pascal Leprince; Guillaume Lebreton
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-01-10

5.  Mid term outcome and quality of life after aortic valve replacement in elderly people: mechanical versus stentless biological valves.

Authors:  I Florath; A Albert; U Rosendahl; T Alexander; I C Ennker; J Ennker
Journal:  Heart       Date:  2005-08       Impact factor: 5.994

6.  Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots.

Authors:  Reza Tavakoli; Peiman Jamshidi; Max Gassmann
Journal:  J Vis Exp       Date:  2017-05-21       Impact factor: 1.355

7.  Application of Regent mechanical valve in patients with small aortic annulus: 3-year follow-up.

Authors:  Dong Zhao; Chunsheng Wang; Tao Hong; Cuizhen Pan; Changfa Guo
Journal:  J Cardiothorac Surg       Date:  2012-09-21       Impact factor: 1.637

8.  Full-root aortic valve replacement with stentless xenograft achieves superior regression of left ventricular hypertrophy compared to pericardial stented aortic valves.

Authors:  Reza Tavakoli; Christoph Auf der Maur; Xavier Mueller; Reinhard Schläpfer; Peiman Jamshidi; François Daubeuf; Nelly Frossard
Journal:  J Cardiothorac Surg       Date:  2015-02-03       Impact factor: 1.637

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.